Influenza affects 5-10% of adults and 20-30% of children each year.1
Whether it’s a typical flu season, or a worst-case pandemic, testing and screening for influenza A and B can help protect patients by enabling appropriate antiviral prescribing or patient isolation. 2,3
The cobas® Influenza A/B assay, a multiplex real-time polymerase chain reaction (PCR) test, running on the innovative cobas® Liat® System, delivers the speed and reliability needed to determine a timely, accurate diagnosis in ~20 minutes.